Augros Cosmetic (AUGR) | Financial Analysis & Statements
Augros Cosmetic Packaging Small-cap Consumer Cyclical
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Income Metrics
Balance Sheet Metrics
Total Assets
13.6M
Total Liabilities
10.3M
Shareholders Equity
3.3M
Debt to Equity
3.09
Cash Flow Metrics
Revenue & Profitability Trend
Augros Cosmetic Income Statement From 2019 to 2023
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | 17.3M |
| Cost of Goods Sold | - | - | - | - | 9.4M |
| Gross Profit | 6.8M | 8.3M | 6.7M | 6.1M | 7.9M |
| Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 45.8% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | - | - | - | - | - |
| Other Operating Expenses | 2.4M | 2.5M | 1.9M | 2.0M | 2.2M |
| Total Operating Expenses | 2.4M | 2.5M | 1.9M | 2.0M | 2.2M |
| Operating Income | - | - | - | - | 490.2K |
| Operating Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 2.8% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | - | - | - | - | 47.2K |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | - | - | - | - | 678.2K |
| Income Tax | - | - | - | - | - |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | -769.7K | 619.9K | 37.3K | -670.4K | 678.2K |
| Net Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 3.9% |
| Key Metrics | |||||
| EBITDA | - | - | - | - | 1.2M |
| EPS (Basic) | €-0.54 | - | €0.03 | €-0.47 | €0.48 |
| EPS (Diluted) | €-0.54 | - | €0.03 | €-0.47 | €0.48 |
| Basic Shares Outstanding | 1425402 | 1441644 | 1243833 | 1426411 | 1412958 |
| Diluted Shares Outstanding | 1425402 | - | 1243833 | 1426411 | 1412958 |
Income Statement Trend
Augros Cosmetic Balance Sheet From 2019 to 2023
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | - | - | - | - | 169.7K |
| Short-term Investments | - | - | - | - | 79.9K |
| Accounts Receivable | 2.6M | 1.3M | 890.2K | 1.6M | 1.8M |
| Inventory | - | - | - | - | 1.2M |
| Other Current Assets | - | - | - | - | - |
| Total Current Assets | 8.3M | 7.7M | 5.0M | 7.6M | 4.1M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | - | - | - | - | 123.5K |
| Goodwill | 243.9K | 243.9K | 243.9K | 243.9K | 499.8K |
| Intangible Assets | - | - | - | - | 12.0K |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | - | 4.2K | 8.3K | 12.5K | 16.7K |
| Total Non-Current Assets | 6.4M | 5.9M | 5.7M | 5.6M | 5.9M |
| Total Assets | 14.7M | 13.6M | 10.8M | 13.2M | 10.0M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 5.8M | 5.1M | 2.5M | 2.6M | 2.7M |
| Short-term Debt | 3.7M | 3.6M | 4.3M | 399.7K | 14.6K |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 50.4K | 77.0K | 700 | 91.9K | 1.7K |
| Total Current Liabilities | - | - | - | - | 4.6M |
| Non-Current Liabilities | |||||
| Long-term Debt | - | - | - | - | 2.0M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | - | - | - | - | 3 |
| Total Non-Current Liabilities | - | - | - | - | 2.1M |
| Total Liabilities | 12.1M | 10.3M | 8.1M | 10.5M | 6.7M |
| Equity | |||||
| Common Stock | - | - | - | - | 200.0K |
| Retained Earnings | - | - | - | - | -5.3M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 2.5M | 3.3M | 2.7M | 2.7M | 3.3M |
| Key Metrics | |||||
| Total Debt | 3.7M | 3.6M | 4.3M | 399.7K | 2.0M |
| Working Capital | 8.3M | 7.7M | 5.0M | 7.6M | -472.7K |
Balance Sheet Composition
Augros Cosmetic Cash Flow Statement From 2019 to 2023
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | - | - | - | - | 678.2K |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 0 | 0 | 0 | 0 | -11.7K |
| Operating Cash Flow | - | - | 4.2K | 4.2K | 670.7K |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | - | - | - | - | -727.8K |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | - | - | - | - | -702.8K |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | - | - | 866.2K |
| Debt Repayment | - | - | - | - | -1.0M |
| Financing Cash Flow | - | - | - | - | -132.1K |
| Free Cash Flow | -1.2M | 1.6M | -910.1K | 108.0K | 837.1K |
| Net Change in Cash | 0 | 0 | 4.2K | 4.2K | -164.2K |
Cash Flow Trend
Augros Cosmetic Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
15.35
Price to Sales
0.59
Profitability Ratios
Profit Margin
-28.50%
Operating Margin
-33.84%
Return on Equity
-447.56%
Return on Assets
-16.64%
Financial Health
Current Ratio
0.56
Debt to Equity
1.07
Beta
-0.32
Per Share Data
EPS (TTM)
€-1.78
Book Value per Share
€-0.69
Revenue per Share
€8.66
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| AUGR | 8.4M | 15.35 | - | -447.56% | -28.50% | 1.07 |
| Verallia S.A | 2.4B | 26.70 | 2.77 | 9.35% | 2.72% | 242.65 |
| Groupe Guillin | 428.9M | 8.66 | 0.68 | 8.09% | 5.63% | 16.64 |
| Gascogne S.A | 88.8M | 38.00 | 0.41 | 0.46% | 0.23% | 124.54 |
| TFF | 355.6M | 14.98 | 0.72 | 4.60% | 6.37% | 76.90 |
Financial data is updated regularly. All figures are in the company's reporting currency.